Notes for P&L

Note 3 Changes in equity

Download Excel

Date Transaction Number of serie B Share capital Quota-
värde
Subscription-
course
Total invested capital (SEK)  
5 Apr 17 Formation 500 50,000 1.00 1.00 50,000  
29 May 17 Share issue 500 50,000 1.00 1.00 50,000  
31 Dec 17 Conditional shareholder contribution* - - - - 1,996,622  
25 Apr 18 Bond issue - 400,000 1.00 - -  
27 Apr 18 Split 2,999,000 - 0.17 - -  
19 Oct 18 Share issue 3,000,000 500,000 0.17 5.26 15,776,962  
14 Jan 20 Share issue 1,389,385 231,564 0.17 10.00 13,893,850  
6 Jul 20 Share issue 2,216,815 369,469 0.17 17.50 38,794,263  
15 Jun 21 Share issue (LTI 2018/21) 200,000 33,334 0.17 11.00 2,200,000  
21 Dec 21 Share issue 1,199,856 199,976 0.17 11.00 13,198,416  
18 Jan 22 Share issue 2,800,086 466,680 0.17 11.00 30,800,946  
Total   13,806,142 2,301,023     116,761,059  

* Inhalation Sciences Sweden AB did in 2017 provide conditional shareholder contributions amounting to 1 996 622 SEK (cash 0.3 mSEK and reverse loans arising in connection with the acquisition of intangible assets by the parent company converted to shareholder contributions amounting to approximately 1.7 mSEK).